RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q2 2013 (Next →)

Filing Date: Aug 14, 2013

Total Value: $754M (100.0% shares, 0.0% debt)

Holdings (29)

ACAD ACADIA PHARMACEUTICALS INC 15.7%

Value $119M Shares 6,529,810 Est. Cost $13.77 Unrealized 0.0%

ACAD ACADIA PHARMACEUTICALS INC 12.0%

Value $90.75M Shares 5,000,000 Est. Cost $13.77 Unrealized 0.0%

— ACHILLION PHARMACEUTICALS IN 8.1%

Value $60.98M Shares 7,455,202 Est. Cost $8.18 Unrealized —

— KERYX BIOPHARMACEUTICALS INC 5.6%

Value $42.27M Shares 5,659,285 Est. Cost $7.47 Unrealized —

SGMO SANGAMO BIOSCIENCES INC 5.6%

Value $41.92M Shares 5,368,094 Est. Cost $8.72 Unrealized 0.0%

— DYAX CORP 5.0%

Value $37.74M Shares 10,908,379 Est. Cost $3.46 Unrealized —

— NEWLINK GENETICS CORP 4.8%

Value $36.29M Shares 1,840,294 Est. Cost $19.72 Unrealized —

— NOVAVAX INC 4.7%

Value $35.2M Shares 17,170,801 Est. Cost $2.05 Unrealized —

— THERAPEUTICSMD INC 4.5%

Value $34.13M Shares 11,262,608 Est. Cost $3.03 Unrealized —

INSM INSMED INC 3.9%

Value $29.1M Shares 2,433,319 Est. Cost $10.22 Unrealized 0.0%

— DERMA SCIENCES INC 3.5%

Value $26.63M Shares 1,994,876 Est. Cost $13.35 Unrealized —

— SUNESIS PHARMACEUTICALS INC 3.2%

Value $24.45M Shares 4,716,296 Est. Cost $5.19 Unrealized —

— XOMA CORP DEL 3.2%

Value $24.32M Shares 6,698,558 Est. Cost $3.63 Unrealized —

SGMO SANGAMO BIOSCIENCES INC 3.1%

Value $23.43M Shares 3,000,000 Est. Cost $8.72 Unrealized 0.0%

— HYPERION THERAPEUTICS INC 2.6%

Value $19.86M Shares 902,858 Est. Cost $22.00 Unrealized —

— RECEPTOS INC 2.6%

Value $19.39M Shares 975,000 Est. Cost $19.89 Unrealized —

— ACHILLION PHARMACEUTICALS IN 2.2%

Value $16.36M Shares 2,000,000 Est. Cost $8.18 Unrealized —

OMER OMEROS CORP 2.0%

Value $14.88M Shares 2,953,004 Est. Cost $4.61 Unrealized 0.0%

— ONCOGENEX PHARMACEUTICALS IN 1.1%

Value $8.461M Shares 863,332 Est. Cost $9.80 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 1.0%

Value $7.724M Shares 436,145 Est. Cost $19.50 Unrealized 0.0%

— KERYX BIOPHARMACEUTICALS INC 1.0%

Value $7.47M Shares 1,000,000 Est. Cost $7.47 Unrealized —

— ENZO BIOCHEM INC 0.9%

Value $6.964M Shares 3,348,029 Est. Cost $2.08 Unrealized —

— DYNAVAX TECHNOLOGIES CORP 0.9%

Value $6.6M Shares 6,000,000 Est. Cost $1.10 Unrealized —

PRTA PROTHENA CORP PLC 0.9%

Value $6.427M Shares 497,807 Est. Cost $9.30 Unrealized 0.0%

— ARROWHEAD RESH CORP 0.8%

Value $6.23M Shares 3,114,755 Est. Cost $2.00 Unrealized —

— EPIZYME INC 0.6%

Value $4.248M Shares 151,000 Est. Cost $28.13 Unrealized —

— SENOMYX INC 0.3%

Value $2.127M Shares 975,610 Est. Cost $2.18 Unrealized —

— TRANZYME INC 0.2%

Value $1.269M Shares 2,700,000 Est. Cost $0.47 Unrealized —

— SAVIENT PHARMACEUTICALS INC 0.0%

Value $228K Shares 1,000,000 Est. Cost $0.23 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACAD	ACADIA PHARMACEUTICALS INC	6,529,810	$119M	15.7%	$13.77	0.0%	COM	004225108
ACAD	ACADIA PHARMACEUTICALS INC	5,000,000	$90.75M	12.0%	$13.77	0.0%	Call	004225108
—	ACHILLION PHARMACEUTICALS IN	7,455,202	$60.98M	8.1%	$8.18	—	COM	00448Q201
—	KERYX BIOPHARMACEUTICALS INC	5,659,285	$42.27M	5.6%	$7.47	—	COM	492515101
SGMO	SANGAMO BIOSCIENCES INC	5,368,094	$41.92M	5.6%	$8.72	0.0%	COM	800677106
—	DYAX CORP	10,908,379	$37.74M	5.0%	$3.46	—	COM	26746E103
—	NEWLINK GENETICS CORP	1,840,294	$36.29M	4.8%	$19.72	—	COM	651511107
—	NOVAVAX INC	17,170,801	$35.2M	4.7%	$2.05	—	COM	670002104
—	THERAPEUTICSMD INC	11,262,608	$34.13M	4.5%	$3.03	—	COM	88338N107
INSM	INSMED INC	2,433,319	$29.1M	3.9%	$10.22	0.0%	COM PAR $.01	457669307
—	DERMA SCIENCES INC	1,994,876	$26.63M	3.5%	$13.35	—	COM PAR $.01	249827502
—	SUNESIS PHARMACEUTICALS INC	4,716,296	$24.45M	3.2%	$5.19	—	COM NEW	867328601
—	XOMA CORP DEL	6,698,558	$24.32M	3.2%	$3.63	—	COM	98419J107
SGMO	SANGAMO BIOSCIENCES INC	3,000,000	$23.43M	3.1%	$8.72	0.0%	Call	800677106
—	HYPERION THERAPEUTICS INC	902,858	$19.86M	2.6%	$22.00	—	COM	44915N101
—	RECEPTOS INC	975,000	$19.39M	2.6%	$19.89	—	COM	756207106
—	ACHILLION PHARMACEUTICALS IN	2,000,000	$16.36M	2.2%	$8.18	—	Call	00448Q201
OMER	OMEROS CORP	2,953,004	$14.88M	2.0%	$4.61	0.0%	COM	682143102
—	ONCOGENEX PHARMACEUTICALS IN	863,332	$8.461M	1.1%	$9.80	—	COM	68230A106
ENTA	ENANTA PHARMACEUTICALS INC	436,145	$7.724M	1.0%	$19.50	0.0%	COM	29251M106
—	KERYX BIOPHARMACEUTICALS INC	1,000,000	$7.47M	1.0%	$7.47	—	Call	492515101
—	ENZO BIOCHEM INC	3,348,029	$6.964M	0.9%	$2.08	—	COM	294100102
—	DYNAVAX TECHNOLOGIES CORP	6,000,000	$6.6M	0.9%	$1.10	—	COM	268158102
PRTA	PROTHENA CORP PLC	497,807	$6.427M	0.9%	$9.30	0.0%	SHS	G72800108
—	ARROWHEAD RESH CORP	3,114,755	$6.23M	0.8%	$2.00	—	COM NEW	042797209
—	EPIZYME INC	151,000	$4.248M	0.6%	$28.13	—	COM	29428V104
—	SENOMYX INC	975,610	$2.127M	0.3%	$2.18	—	COM	81724Q107
—	TRANZYME INC	2,700,000	$1.269M	0.2%	$0.47	—	COM	89413J102
—	SAVIENT PHARMACEUTICALS INC	1,000,000	$228K	0.0%	$0.23	—	NOTE 4.750% 2/0	80517QAA8